Esomeprazole-based therapy in Helicobacter pylori eradication: A meta-analysis

Digestive and Liver Disease

Volumn 36, Issue 4, 2004, Pages 253-259

  Gisbert, J P ^a   Pajares, J M ^a  

^a HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

Author keywords

Esomeprazole; Helicobacter pylori; Proton pump inhibitor

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; CLARITHROMYCIN; ESOMEPRAZOLE; METRONIDAZOLE; OMEPRAZOLE; PLACEBO; PROTON PUMP INHIBITOR; ANTIINFECTIVE AGENT; ANTIULCER AGENT;

CLINICAL PROTOCOL; CLINICAL TRIAL; CONFIDENCE INTERVAL; DRUG EFFICACY; ERADICATION THERAPY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; META ANALYSIS; PUBLICATION; REVIEW; RISK ASSESSMENT; SIDE EFFECT; STATISTICAL ANALYSIS; SYSTEMATIC REVIEW; CONTROLLED CLINICAL TRIAL; DRUG COMBINATION; DRUG EFFECT; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ANTI-BACTERIAL AGENTS; ANTI-ULCER AGENTS; CLARITHROMYCIN; DRUG THERAPY, COMBINATION; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; OMEPRAZOLE; RANDOMIZED CONTROLLED TRIALS; TREATMENT OUTCOME;

EID: 3543143017     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dld.2003.12.010     Document Type: Article

References (18)

1. Spencer CM, Faulds D. Esomeprazole. Drugs 2000;60:321-9.
2. Scott LJ, Dunn CJ, Mallarkey G, Sharpe M. Esomeprazole: a review of its use in the management of acid-related disorders. Drugs 2002;62:1503-38.
3. Johnson TJ, Hedge DD. Esomeprazole: a clinical review. Am J Health Syst Pharm 2002;59:1333-9.
4. Johnson DA. Review of esomeprazole in the treatment of acid disorders. Expert Opin Pharmacother 2003;4:253-64.
5. Kale-Pradhan PB, Landry HK, Sypula WT. Esomeprazole for acid peptic disorders. Ann Pharmacother 2002;36:655-63.
6. Miner Jr PB, Katz PO, Chen Y, Mark B, Sostek MB. Esomeprazole 40 mg provides more effective intragastric acid suppression at steady state than standard doses of other proton pump inhibitors. Gastroenterology 2003;124:232A.
7. Gisbert JP, Pajares JM. Helicobacter pylori therapy: first-line options and rescue regimen. Dig Dis 2001;19:134-43.
8. Gatta L, Perna F, Figura N, Ricci C, Holton J, D'Anna L, et al. Antimicrobial activity of esomeprazole versus omeprazole against Helicobacter pylori. J Antimicrob Chemother 2003;51:439-42.
9. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996;17:1-12.
10. Laine L, Fennerty MB, Osato M, Sugg J, Suchower L, Probst P, et al. Esomeprazole-based Helicobacter pylori eradication therapy and the effect of antibiotic resistance: results of three US multicenter, double-blind trials. Am J Gastroenterol 2000;95:3393-8.
11. Tulassay Z, Kryszewski A, Dite P, Kleczkowski D, Rudzinski J, Bartuzi Z, et al. One week of treatment with esomeprazole-based triple therapy eradicates Helicobacter pylori and heals patients with duodenal ulcer disease. Eur J Gastroenterol Hepatol 2001;13:1457-65.
12. Vasil'ev Iu V, Kas'ianenko VI. Efficacy of the one week treatment with esomeprazole (nexium), clarythromycin, and amoxycillin of duodenal ulcer associated with Helicobacter pylori. Eksp Klin Gastroenterol 2002;102:47-51.
13. Veldhuyzen Van Zanten S, Lauritsen K, Delchier JC, Labenz J, De Argila CM, Lind T, et al. One-week triple therapy with esomeprazole provides effective eradication of Helicobacter pylori in duodenal ulcer disease. Aliment Pharmacol Ther 2000;14:1605-11.
14. Veldhuyzen Van Zanten S, Machado S, Lee J. One-week triple therapy with esomeprazole, clarithromycin and metronidazole provides effective eradication of Helicobacter pylori infection. Aliment Pharmacol Ther 2003;17:1381-7.
15. Madisch A, Bayerdoerffer E, Baestlein E, Schneider-Brachert W, Haenel X, Piehler P, et al. 7-day triple therapy with esomeprazole, levofloxacin and amoxycillin is effective in patients with metronidazole- and clarithromycin-sensitive and -resistant H. pylori strains. Gastroenterology 2003;124:772.
16. Miehlke S, Ebert S, Kirsch C, Schneider-Brachert W, Baestlein E, Haferland C. One-week triple therapy with esomeprazole, clarithromycin and metronidazole is highly effective in eradicating Helicobacter pylori in the absence of antimicrobial resistance-a prospective randomized multicenter trial. Gastroenterology 2003;124:M1493.
17. Bayerdorffer E, Hansky K, Schneider-Brachert W, Kirsch C, Kroettinger A, Bästlein E, et al. Treatment of Helicobacter pylori resistant to both metronidazole and clarithromycin-prospective, randomized trial comparing a 7-day rifabutin-based triple therapy with a high-dose omeprazole/amoxicillin dual therapy (interims analysis). Gut 2002;51:A91.
18. Laine L. Review article: esomeprazole in the treatment of Helicobacter pylori. Aliment Pharmacol Ther 2002;16:115-8.